Clinical Trials Directory

Trials / Completed

CompletedNCT04724434

Follow-up Study of COVID-19 Patients in the District Konstanz

Single Center Prospective Controlled Follow-up Study of COVID-19 Patients in the District Konstanz (FSC19-KN)

Status
Completed
Phase
Study type
Observational
Enrollment
526 (actual)
Sponsor
Hegau-Bodensee-Klinikum Singen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This is a prospective single-center study for the follow-up of SARS-CoV-2 positive patients in the district of Konstanz (LKN). As part of the coronavirus pandemic, patients with SARS-CoV-2 infection are currently being treated in the clinics of the LKN's health network at the Singen (Hegau-Bodensee Clinic) and Konstanz (Konstanz Clinic) locations. So far, there is little data on the long-term effects of SARS-CoV-2 infection. As part of this study, the disease progression of these patients will be monitored. Study objective: Prospective, controlled follow-up observation of SARS-CoV-2 positive patients regarding their secondary diseases and quality of life.

Conditions

Timeline

Start date
2020-12-04
Primary completion
2021-07-17
Completion
2024-12-31
First posted
2021-01-26
Last updated
2025-03-12

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT04724434. Inclusion in this directory is not an endorsement.